{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"CG Oncology, Inc."},"Symbol":{"label":"Symbol","value":"CGON"},"Address":{"label":"Address","value":"400 SPECTRUM CENTER DRIVE,SUITE 2040, Â¿IRVINE, California, 92618, United States"},"Phone":{"label":"Phone","value":"(949) 409-3700"},"Industry":{"label":"Industry","value":null},"Sector":{"label":"Sector","value":null},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life."},"CompanyUrl":{"label":"Company Url","value":"https://www.cgoncology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ambaw Bellete","title":"President & Chief Operating Officer"},{"name":"Arthur Kuan","title":"Chairman & Chief Executive Officer"},{"name":"Swapnil Bhargava","title":"Chief Technical Officer"},{"name":"Vijay Kasturi","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}